Shares of Xylem Inc. (NYSE:XYL – Get Free Report) have earned an average rating of “Hold” from the eighteen brokerages that are covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, seven have assigned a hold recommendation and nine have issued a buy recommendation on the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is $121.31.
XYL has been the topic of several research reports. Mizuho set a $99.00 price target on shares of Xylem in a research report on Wednesday. Jefferies Financial Group upped their price objective on Xylem from $145.00 to $150.00 and gave the stock a “buy” rating in a research report on Monday, August 24th. The Goldman Sachs Group reduced their price objective on Xylem from $160.00 to $138.00 and set a “buy” rating on the stock in a research note on Wednesday. UBS Group decreased their target price on Xylem from $112.00 to $99.00 and set a “neutral” rating for the company in a report on Thursday. Finally, Wolfe Research started coverage on Xylem in a research note on Tuesday, September 15th. They set a “peer perform” rating for the company.
Read Our Latest Analysis on XYL
More Xylem News
Here are the key news stories impacting Xylem this week:
- Positive Sentiment: Director D. Christian Koch purchased 11,000 Xylem shares for approximately $985,600 at an average price of $89.60. The transaction increased his direct holdings more than eightfold and may signal confidence that the recent selloff has created an attractive entry point. Insider purchase report
- Positive Sentiment: Some analysts continue to see longer-term value. RBC Capital reaffirmed its buy rating, while RBC’s new coverage assigned a moderate-buy rating and a $125 price target, implying substantial upside from recent levels. RBC rating report
- Neutral Sentiment: Xylem announced divestitures and a new three-segment operating structure. The changes could sharpen strategic focus and improve portfolio efficiency, but execution and transition risks remain. Xylem restructuring report
- Negative Sentiment: Xylem’s latest quarter missed expectations: EPS was $1.44 versus $1.45 expected, revenue was $2.20 billion versus $2.28 billion expected, and sales declined 3% year over year. Management’s new 2026 adjusted-EPS ceiling of $5.45 is below the prior $5.55 floor, reinforcing concerns about weaker growth.
- Negative Sentiment: Barclays downgraded Xylem to equal weight from overweight, JPMorgan lowered its rating to underweight, and UBS, Stifel, BNP Paribas Exane, Citigroup and Oppenheimer reduced price targets. The revisions reflect diminished near-term earnings and valuation expectations. Barclays downgrade report
- Negative Sentiment: Levi & Korsinsky announced an investigation into potential securities-law violations related to investor losses, adding legal uncertainty and another possible overhang for XYL shareholders. Investigation announcement
Xylem Price Performance
Shares of NYSE XYL opened at $92.41 on Monday. The firm has a market cap of $21.19 billion, a PE ratio of 20.44, a PEG ratio of 1.54 and a beta of 1.01. The firm has a fifty day moving average of $105.05 and a 200 day moving average of $117.57. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.02 and a current ratio of 1.39. Xylem has a one year low of $87.40 and a one year high of $152.43.
Xylem (NYSE:XYL – Get Free Report) last released its quarterly earnings data on Tuesday, October 27th. The industrial products company reported $1.44 EPS for the quarter, missing analysts’ consensus estimates of $1.45 by ($0.01). Xylem had a net margin of 11.94% and a return on equity of 12.06%. The business had revenue of $2.20 billion during the quarter, compared to analyst estimates of $2.28 billion. During the same quarter in the previous year, the company posted $1.37 EPS. The firm’s revenue was down 3.0% on a year-over-year basis. As a group, research analysts predict that Xylem will post 5.45 EPS for the current fiscal year.
Xylem Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 24th. Shareholders of record on Thursday, August 27th were paid a $0.43 dividend. The ex-dividend date was Thursday, August 27th. This represents a $1.72 dividend on an annualized basis and a yield of 1.9%. Xylem’s payout ratio is currently 38.05%.
Insider Buying and Selling at Xylem
In related news, Director D Koch purchased 11,000 shares of the business’s stock in a transaction dated Thursday, October 29th. The stock was acquired at an average price of $89.60 per share, for a total transaction of $985,600.00. Following the completion of the purchase, the director directly owned 12,247 shares of the company’s stock, valued at $1,097,331.20. This trade represents a 882.12% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.32% of the company’s stock.
Institutional Trading of Xylem
Institutional investors have recently bought and sold shares of the company. Oregon Public Employees Retirement Fund raised its stake in Xylem by 0.4% in the 1st quarter. Oregon Public Employees Retirement Fund now owns 27,923 shares of the industrial products company’s stock valued at $3,337,000 after purchasing an additional 100 shares during the last quarter. Thrive Wealth Management LLC boosted its stake in shares of Xylem by 2.1% during the 2nd quarter. Thrive Wealth Management LLC now owns 5,032 shares of the industrial products company’s stock worth $595,000 after purchasing an additional 104 shares during the last quarter. World Investment Advisors boosted its stake in shares of Xylem by 3.7% during the 1st quarter. World Investment Advisors now owns 3,319 shares of the industrial products company’s stock worth $397,000 after purchasing an additional 119 shares during the last quarter. Aventus Investment Advisors Inc. grew its holdings in shares of Xylem by 66.7% during the second quarter. Aventus Investment Advisors Inc. now owns 300 shares of the industrial products company’s stock worth $35,000 after buying an additional 120 shares in the last quarter. Finally, Aprio Wealth Management LLC grew its holdings in shares of Xylem by 6.2% during the third quarter. Aprio Wealth Management LLC now owns 2,114 shares of the industrial products company’s stock worth $214,000 after buying an additional 123 shares in the last quarter. 87.96% of the stock is currently owned by hedge funds and other institutional investors.
About Xylem
Xylem Inc (NYSE: XYL) is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.
The company’s products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.
See Also
- Five stocks we like better than Xylem
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
- Oracle’s AI Spending Peak Is in Sight—Can the Stock Recover?
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
